BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph(+) leukemias? Cruz-Rodriguez N, Tang H, Bateman B, Tang W, et al. Leukemia 2024;38:1885-1893.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Cruz-Rodriguez N, Tang H, Bateman B, Tang W, et al. BCR::ABL1 Proteolysis-targeting chimeras (PROTACs): The new frontier in the treatment of Ph(+) leukemias? Leukemia 2024;38:1885-1893.
PMID: 39098922